These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35839717)

  • 1. In-silico functional and structural annotation of hypothetical protein from Klebsiella pneumonia: A potential drug target.
    Singh V; Dhankhar P; Dalal V; Tomar S; Kumar P
    J Mol Graph Model; 2022 Nov; 116():108262. PubMed ID: 35839717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
    Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
    J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising antibacterials for LLM of
    Rathi R; Kumari R; Pathak SR; Dalal V
    J Biomol Struct Dyn; 2023; 41(15):7277-7289. PubMed ID: 36073371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential inhibitors of FemC to combat
    Rathi R
    J Biomol Struct Dyn; 2023 Dec; 41(20):10495-10506. PubMed ID: 36524526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM/MM.
    Dalal V; Dhankhar P; Singh V; Singh V; Rakhaminov G; Golemi-Kotra D; Kumar P
    Protein J; 2021 Apr; 40(2):148-165. PubMed ID: 33421024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of the beta-lactamase protein using comparative modelling, drug screening and molecular dynamics studies to understand the resistance of β-lactam antibiotics.
    Alazmi M
    J Mol Model; 2020 Jul; 26(8):200. PubMed ID: 32638150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtractive Genomics, Molecular Docking and Molecular Dynamics Simulation Revealed LpxC as a Potential Drug Target Against Multi-Drug Resistant Klebsiella pneumoniae.
    Ahmad S; Navid A; Akhtar AS; Azam SS; Wadood A; Pérez-Sánchez H
    Interdiscip Sci; 2019 Sep; 11(3):508-526. PubMed ID: 29721784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling, docking and structure-based virtual screening for new inhibitor identification of
    Panda SK; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2020 Apr; 38(7):1887-1902. PubMed ID: 31179839
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational investigation of potent inhibitors against YsxC: structure-based pharmacophore modeling, molecular docking, molecular dynamics, and binding free energy.
    Kumari R; Rathi R; Pathak SR; Dalal V
    J Biomol Struct Dyn; 2023 Feb; 41(3):930-941. PubMed ID: 34913841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure to function prediction of hypothetical protein KPN_00953 (Ycbk) from Klebsiella pneumoniae MGH 78578 highlights possible role in cell wall metabolism.
    Teh BA; Choi SB; Musa N; Ling FL; Cun ST; Salleh AB; Najimudin N; Wahab HA; Normi YM
    BMC Struct Biol; 2014 Feb; 14():7. PubMed ID: 24499172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study.
    Alabbas AB
    Saudi Pharm J; 2023 Sep; 31(9):101745. PubMed ID: 37638221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays.
    Skariyachan S; Manjunath M; Bachappanavar N
    J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Molecular Docking and Dynamics Approach to Screen Potent Inhibitors Against Fosfomycin Resistant Enzyme in Clinical Klebsiella pneumoniae.
    Thirumal Kumar D; Lavanya P; George Priya Doss C; Tayubi IA; Naveen Kumar DR; Francis Yesurajan I; Siva R; Balaji V
    J Cell Biochem; 2017 Nov; 118(11):4088-4094. PubMed ID: 28409871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
    Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN
    J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.